Case Reports in Orthopedics

Case Reports in Orthopedics / 2019 / Article

Case Report | Open Access

Volume 2019 |Article ID 1871856 | 8 pages |

Total Knee Arthroplasty in Ochronosis Arthropathy: A Case Report and Systematic Review

Academic Editor: Werner Kolb
Received20 Jan 2019
Accepted12 Sep 2019
Published09 Oct 2019


Introduction. Ochronosis arthropathy (OcA) is a rare condition which may be treated with total knee arthroplasty (TKA) at the end stage. The condition is often discovered only intraoperatively and the ideal choice of TKA is unknown. Case Presentation. A 54-year-old male with worsening chronic bilateral mechanical knee pain had failed conservative therapy. Posterior stabilised (PS), cemented TKA and patella resurfacing was performed. Intraoperatively, collagenous structures such as the menisci and cartilage were noted to be black. Histological examination showed deposition of large amorphous brown material suggestive of ochronosis. He recovered well and underwent TKA of the contralateral knee the following year. At 2 years postindex TKA, his outcome scores improved and he was satisfied. Discussion and Conclusion. With increasing TKA performed worldwide, a surgeon may eventually be surprised by the above findings once in their lifetime. However, OcA may be considered a likely diagnosis and it is safe to proceed with TKA. There is no particular TKA design that proved to be superior in our systematic review of 19 publications regarding TKA as all reported good outcomes. However, as the pathogenesis of OcA appears to be inflammatory in nature, we suggest using cemented PS TKA with resurfacing of the patella.

1. Introduction

Ochronosis arthropathy is one of the manifestations in patients with alkaptonuria [1]. Alkaptonuria is a rare autosomal recessive disorder with an estimated prevalence ranging from 1 : 19,000 to 1 : 1,000,000 [1]. The disorder leads to a defective enzyme homogentisate 1,2-dioxygenase (HGD), resulting in accumulation of homogentisic acid [1]. They may deposit in collagen-rich connective tissues to form yellowish discoloration, hence the term ochronosis (ochre: yellow in Greek) [1]. These changes make the connective tissue more brittle and chemically irritate the joint, causing degeneration of the joint with eventual end-stage arthritis, with the knee being most commonly affected [1].

Total knee arthroplasty (TKA) has been suggested as an effective treatment for end-stage ochronosis arthropathy but these are limited to case reports [28]. A critical review of 13 case reports seemed to suggest no difference between cemented and cement-less TKA for ochronosis arthropathy [8]. However, other aspects of TKA such as cruciate substitution or retaining and patella resurfacing were not studied.

Although the condition is rare, the aging society and increasing volume of TKA will mean surgeons may eventually encounter this [9]. Owing to its rarity, the ideal choice of implant has not been elucidated. In this study, we present a case of ochronosis arthropathy treated with TKA to contribute to the literature. Secondly, through a systematic review, we aim to determine the appropriate choice of TKA implant for this condition.

2. Case Study

A 54-year-old male presented to us with bilateral mechanical knee pain with the right knee being worse. Functionally, he could not climb stairs and could only walk for about 5 minutes.

His significant medical history included diabetes mellitus, ischaemic stroke, cervical spondylosis, left frozen shoulder, right calcaneal tendon rupture which was repaired 14 years prior, and right lower limb peripheral vascular disease which was treated with angioplasty 1 month prior.

On physical examination, there was medial joint line tenderness. The range of motion (ROM) was 5° to 100° with palpable crepitus. The dorsalis pedis pulse was not palpable, but the posterior tibialis was palpable.

His preoperative Oxford knee score (OKS) [10] was 9, while his Knee Society (KS) function score [11] was 0. The KS knee score was unavailable.

X-rays of the knees showed advanced osteoarthritic changes (Figure 1).

Having failed conservative therapy, TKA was offered and was agreed upon after informed consent. A midline incision was made, followed by a medial parapatellar approach. Upon everting the patella, it was noted that the patella tendon, menisci, cruciate ligaments, and cartilage over femur, patella, and trochlea were black in colour (Figure 2). With no signs suggestive of infection or malignancy, cemented posterior stabilised TKA (NexGen, Zimmer) was performed using iASSIST navigation. The patella has resurfaced.

Intraoperative tissue samples were sent for histological analysis which were reported to have deposition of large amorphous brown material in the above structures including the synovium, suggestive of ochronosis.

Subsequent physical examination revealed dark pigmentation of his sclerae (Figures 3(a) and 3(b)). We were unable to appreciate similar pigmentation in the ears. His urine appeared normal, until the addition of sodium hydroxide turned it dark (Figure 3(c)).

At 1 year postoperation, the symptoms in his left knee had progressed. On examination, there was medial joint line tenderness, and ROM was 15° to 90° with crepitus. Only the dorsalis pedis pulse was palpable, but the patient was advised by the vascular surgeon to manage conservatively. The patient then proceeded with left TKA.

With the same technique and implant as the right side, left TKA was performed. The operative findings were similar to the right knee. Histological analysis revealed similar findings as above.

In both instances, the patient received compression stockings, mechanical calf pumps, and 100 mg of aspirin once daily as postoperative thromboprophylaxis. He underwent the same postoperative physiotherapy protocol as other TKA patients in the institution. Continuous passive motion from 0° to 60° was started on the day of operation followed by 0° to 90° on postoperative day (POD) 1, and then 0° to maximal flexion as tolerated from POD2 onwards. Full-weight bearing was allowed immediately postoperation.

At 2 years after the second TKA, he was happy with the functional outcome. He had ROM of 0° to 90° bilaterally. His Knee Society (KS) function score was 70 and KS knee score was 73 bilaterally. His Oxford Knee Score (OKS) was 40. The X-rays showed satisfactory position and alignment (Figure 4).

The patient was informed that data from the case would be submitted for publication, and gave his written consent.

3. Discussion

In ochronosis arthropathy, the deposition of homogentisic acid is not limited to the knees. Any collagen-rich connective tissues such as the other joints and cardiovascular system may be affected [1]. These may explain our patient’s past medical history of cervical spondylosis, frozen shoulder, calcaneal tendon rupture, ischaemic stroke, and peripheral vascular disease.

To better understand the presentation and treatment success of the disease, we performed a systematic review using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [12] framework as guidance. There was no existing review protocol for this study in the Database of Abstracts of Reviews of Effects (DARE) or Cochrane database or was this study registered. Databases of PubMed and Embase were searched using the terms “ochronosis knee arthroplasty”, “alkaptonuria knee arthroplasty”, “ochronotic knee arthroplasty”, “ochronosis knee replacement”, and “alkaptonuria knee replacement”. All studies containing the search terms up to October 2017 were eligible for inclusion. Titles and abstracts were screened, and full articles were obtained whenever possible using institution’s access only. From the articles identified, we checked for references which were not brought up from the initial search and included them in our study. Studies were excluded if they were duplicates, non-English, or no full text available. Data extracted from the full articles included age, gender, number of joints involved, side of surgery, type of implant, when the diagnosis was made, duration of follow-up, and any indicator of preoperative and postoperative outcome, for example, range of motion, ambulatory status, complaints, or outcome scores. For the type of implant, we were interested in whether it is cemented or cement-less and cruciate substituting (CS) or posterior stabilised (PS). If no information regarding these were available from the articles, the senior author would identify the type of implants based on the radiographs provided in the relevant study. Risk of bias was assessed based on the level of evidence of the article [13]. The descriptive outcomes were regarded as the principal summary measure. Whenever possible, basic statistical data will be analysed, for example, mean age, gender distribution, and mean follow-up.

A total of 19 articles between 2000 and 2016 were included in our study [28, 1425] (Figure 5, Table 1). The characteristics and results of the articles are presented in Table 1. Excluding our patients, there were 19 patients comprising of 26 TKA, with the mean age of , and 9 females (47.4%). In 10 patients (52.6%), the diagnosis of ochronosis was only confirmed postoperatively. From the data available, the average preoperative range of motion (ROM) was in 14 knees, and the postoperative ROM was in 12 knees. PS was used in 10 knees, while 5 knees had CR and 11 were unknown. The patella has resurfaced in 6 knees, retained in 9 knees, and unknown in 11 knees. Cement was used in 14 knees, not used in 3 knees, and unknown in 9 knees. From the limited outcome measures, patients appeared to have good outcome with majority claiming independent ambulatory status with minimal or no complaints. One article reported intraoperative complication of the patella tendon rupture, which was repaired with no mention of any extensor mechanism compromise in the final outcome [6]. All articles were of case reports or level IV evidences as they were part of case series [13], subjecting them to the potential of bias.

AuthorYearTypeNo. of patientsNo. of TKAAgeGenderSideCemented/cement-lessPS/CRPatellaFollow-upPreoperative measurementPostoperative measurementKnown diagnosis

This studyR1254MaleBilateralCementedPSReplaced24 monthsRight ROM 5-100, left ROM 15-90. OKS: 9. KSFS: 0OKS: 40, KSFS: 70, KSKS: 73 bilateral. ROM: 0-90 bilateralPostop
Karaoğlu et al.2016R1155MaleLeftCementedCRReplaced10 yearsROM: 0-120. No laxityNone. Full activity, no pain, satisfied with outcome. X-ray normalPreop
Cieszyński et al.2016R1162MaleLeftNo mention. No X-rayNo X-rayNo mention. No X-rayUnknownUnknownNonePostop
da Silva Martins Ferreira et al.2014R1267MaleBilateralCementedPSRetainedRight: 18 months. Left: 6 monthsUnknownRight knee ROM: 0-110. Left knee ROM: 0-120. Asymptomatic, walks without gait supportPreop
Patel2015R1158FemaleRightCementedPSRetained18 monthsAntalgic gait. ROM: 0-95KS: 84. X-ray normalPostop
Sahoo et al.2014R1251MaleBilateralCementedPSReplaced28 monthsROM 10-20 bilaterallyWalking pain free. ROM 0-90 bilaterally. X-ray normalPostop
Acar et al.2013R1162FemaleLeftCementedCRRetained18 monthsUnknownNone. Adequate ROM and pain free. X-ray normalPreop
Ozmanevra et al.2013R1269MaleBilateralCementedPSReplaced2 yearsBMI 30.2. Right ROM: 0-110. Left ROM: 0-114Bilateral ROM 0-114. HSS score 95 bilaterally. X-ray normalPostop
Reed et al.2012R1155FemaleLeftCementedNo X-rayRetained3 monthsIndependent ambulation. Antalgic gait. ROM 5-120. No laxityExcellent stability, pain relief, ROM 0-110. X-ray normalPostop
Chang et al.2009R1177MaleLeftNo mention. No X-rayNo X-rayNo mention. No X-rayUnknownUnknownUnknownPostop
Kopeć et al.2007R1266FemaleBothCementedPSRetainedUnknownRight ROM 0-90, left ROM 0-100ROM 0-100 bilaterally. No painPreop
Kastsiuchenka et al.2013R1148FemaleUnknownNo mention. No X-rayNo X-rayNo mention. No X-rayUnknownNoneNonePostop
Harun et al.2014R1160FemaleLeftCemented. Vanguard biometNo X-rayRetainedUnknownIndependent ambulation. Antalgic gait. ROM: 10-110None. Adequate ROM, free of pain. X-ray normalPostop
Abimbola et al.2011R1148MaleLeftCemented. GENESIS SPC S&NCRReplaced2 yearsIndependent ambulation. ROM: 0-130. No laxityNone. Full activities, no pain, very satisfiedPreop
Araki et al.2009R1256MaleBilateralCement-lessNo X-rayNo mention. No X-ray6 yearsNoneReturned to relatively normal activities. Walking well with crutches and without significant knee and hip symptomsPostop
Demir2003R1270MaleBilateralCementedInadequate X-rayNo mention. X-ray inadequate14 yearsUnknownNoneUnknown
Aydoğdu et al.2000R1148MaleLeftCement-less. APS, AlloPro, BaarPSReplaced4 yearsWalks with cane, 10 minutes, ROM: 25-125. KSKS: 35, KSFS: 45ROM 5-120. KSKS: 85. KSFS: 50 (limited by hip, contralateral knee, and spine). X-ray normalPreop
Fisher and Davis2004R1264FemaleBilateralNo mention. Inadequate X-rayCRNo mention. X-ray inadequate3 yearsNoneNone. Able to walk without walking aidsPreop
Fontao-Fernández et al.2010S1171FemaleLeftNo mention. No X-rayNo X-rayNo mention. No X-rayUnknownUnknownNone. No complications with stability in the fixation of the implantsPreop
Spencer et al.2004S1162FemaleUnknownBiomet AGC. No X-rayNo X-rayNo mention. No X-ray7 yearsUnknownNone. Asymptomatic. Independently mobile. X-ray normalPreop

Abbreviations: R = case report; S = case series; ROM = range of motion; PS = posterior stabilised; CR = cruciate retaining; OKS = Oxford Knee Score; KS = Knee Society clinical rating system; KSKS = Knee Society knee score; KSFS = Knee Society function score; HSS = hospital for special surgery.

As per many other studies presented, the diagnosis of ochronosis arthropathy in our case was only made postoperatively. The finding of black connective tissues by an orthopaedic surgeon may be the first point of suspicion for alkaptonuria in the patient. Cutaneous manifestations such as dark pigmentation of the ear may not be obvious, especially in patients with pigmented skin such in our case. The black connective tissues may cause unnerving surprise to the surgeon. However, ochronosis arthropathy is a likely diagnosis and is therefore safe to proceed with TKA. The patient is likely to benefit from the procedure, given the good outcomes described in the reports presented. The next step is then to decide the type of implant that is suitable for this disease.

From our systematic review, we found most cases used cemented TKA. In a meta-analysis, cemented TKA offered better survival rate compared to cement-less TKA [26]. However, it was discussed that it may be due to cement-less TKA being used in younger and more active patients with good bone stock, for example, those reported by Aydoğdu et al. and Araki et al. [20, 22, 26]. However, ochronosis arthropathy has an element of inflammation [1], which may affect the bone quality in the long run, albeit no report of early loosening or subsidence in the reported cases that used cement-less TKAs. Nevertheless, we feel that cemented TKA should be considered for ochronosis arthropathy, as per for inflammatory arthritis such as rheumatoid arthritis [27, 28]. Furthermore, cemented TKA offers advantages such as easier technique ensuring greater primary stability, and delivery of local antibiotics [29].

In inflammatory disease, the posterior cruciate ligament may be eroded over time and cause instability in a cruciate retaining TKA [30]. This may cause failure of TKA and necessitate a revision surgery [30]. Similarly, with the potential inflammatory component of ochronosis arthropathy, a posterior substituting TKA may be the preferred option. In our case, the intraoperative assessment of the pigmented ligament was of questionable reliability and hence the decision for posterior substituting TKA.

With regards to the patella, we also prefer to resurface it, as the pathology of ochronosis involves depositing of the offending homogentisic acid in the cartilage [1]. If retained, there is a possibility of chemical irritation causing joint inflammation [1], and therefore knee pain following TKA. This is interpreted from a better pain relief and functional outcomes in rheumatoid patients who had patella resurfacing in a prospective randomized control trial [31]. However, the patella tendon may be brittle from the chemical irritation and deposition of homogentisic acid [1]. The surgeon would need to be mindful during the eversion of the patella or perform the resurfacing with only patella retraction [32].

Although there are no data from the literature regarding postoperative rehabilitation protocol, we feel that it was no different from a standard TKA patient from our limited experience. Thromboprophylaxis may be given and early physiotherapy may be attempted.

There are limitations to our systematic review; however, the findings from this study are based on a collection of case reports which carry their own bias. The number of case reports was limited, with the most recent available report being in 2016, which was 1 year from the commencement of our systematic review. Apart from ours and reports from Patel [5], Ozmanevra et al. [8], and Aydoğdu et al. [22], there are no formal outcome scoring which makes the comparison across studies difficult. Furthermore, not all information regarding the implants used was available, which limits our interpretation. Our suggested choice of implant is also based on a theoretical understanding of its pathology having an inflammatory component, hence drawing inferences using data from rheumatoid arthritis patients may overestimate the severity of ochronosis arthropathy. There remains more to be known regarding the appropriate implant for this rare condition, and it is hoped that future case reports or series will include more details regarding the surgery and outcome.

In conclusion, ochronosis arthropathy should be considered as a diagnosis when faced with black connective tissue intraoperatively. Surgeons may proceed with TKA as it provides a good long-term outcome for end-stage arthropathy. As there in an inflammatory component in ochronosis arthropathy, we suggest using cemented PS TKA with resurfacing of the patella.


This work was presented at the 20th Asia Pacific Orthopaedic Association Congress, Antalya, Turkey, in April 2018.

Conflicts of Interest

The authors declare that there is no conflict of interest regarding the publication of this article.


  1. J. A. Gil, J. Wawrzynski, and G. R. Waryasz, “Orthopedic manifestations of ochronosis: pathophysiology, presentation, diagnosis, and management,” The American Journal of Medicine, vol. 129, no. 5, pp. 536.e1–536.e6, 2016. View at: Publisher Site | Google Scholar
  2. S. Karaoğlu, F. Karaaslan, and M. U. Mermerkaya, “Long-term result of arthroplasty in the treatment of a case of ochronotic arthropathy,” Acta Orthopaedica et Traumatologica Turcica, vol. 50, no. 5, pp. 584–586, 2016. View at: Publisher Site | Google Scholar
  3. K. Cieszyński, J. Podgórny, A. Mostowska, P. P. Jagodziński, and A. E. Grzegorzewska, “Alkaptonuria: a disease with dark brown urine,” Polskie Archiwum Medycyny Wewnętrznej, vol. 126, no. 4, pp. 284-285, 2016. View at: Publisher Site | Google Scholar
  4. A. M. da Silva Martins Ferreira, F. Lima Santos, A. M. Castro Costa, B. M. Pereira Barbosa, R. M. Reis Rocha, and J. F. Fontes Lebre, “Knee osteoarthrosis secondary to ochronosis – clinical case,” Revista Brasileira de Ortopedia, vol. 49, no. 6, pp. 675–680, 2014. View at: Publisher Site | Google Scholar
  5. V. G. Patel, “Total knee arthroplasty in ochronosis,” Arthroplasty Today, vol. 1, no. 3, pp. 77–80, 2015. View at: Publisher Site | Google Scholar
  6. M. M. Sahoo, S. K. Mahapatra, G. C. Sethi, and S. K. Dash, “Patellar ligament rupture during total knee arthroplasty in an ochronotic patient,” Acta Orthopaedica et Traumatologica Turcica, vol. 48, no. 3, pp. 367–370, 2014. View at: Publisher Site | Google Scholar
  7. M. A. Acar, Ö. F. Erkocak, B. K. Aydin, E. Altan, H. Şenaran, and N. M. Elmadağ, “Patients with black hip and black knee due to ochronotic arthropathy: case report and review of literature,” Oman Medical Journal, vol. 28, no. 6, pp. 448-449, 2013. View at: Publisher Site | Google Scholar
  8. R. Ozmanevra, O. Güran, V. Karatosun, and I. Günal, “Total knee arthroplasty in ochronosis: a case report and critical review of the literature,” Eklem Hastalıkları ve Cerrahisi, vol. 24, no. 3, pp. 169–172, 2013. View at: Publisher Site | Google Scholar
  9. M. C. S. Inacio, E. W. Paxton, S. E. Graves, R. S. Namba, and S. Nemes, “Projected increase in total knee arthroplasty in the United States - an alternative projection model,” Osteoarthritis and Cartilage, vol. 25, no. 11, pp. 1797–1803, 2017. View at: Publisher Site | Google Scholar
  10. N. D. Clement, D. MacDonald, and A. H. R. W. Simpson, “The minimal clinically important difference in the Oxford knee score and Short Form 12 score after total knee arthroplasty,” Knee Surgery, Sports Traumatology, Arthroscopy, vol. 22, no. 8, pp. 1933–1939, 2014. View at: Publisher Site | Google Scholar
  11. J. N. Insall, L. D. Dorr, R. D. Scott, and W. N. Scott, “Rationale, of The Knee Society Clinical Rating System,” Clinical Orthopaedics and Related Research, vol. 248, pp. 13-14, 1989. View at: Google Scholar
  12. D. Moher, A. Liberati, J. Tetzlaff, D. G. Altman, and The PRISMA Group, “Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement,” PLoS Medicine, vol. 6, no. 7, article e1000097, 2009. View at: Publisher Site | Google Scholar
  13. J. G. Wright, M. F. Swiontkowski, and J. D. Heckman, “Introducing levels of evidence to the journal,” The Journal of Bone and Joint Surgery. American Volume, vol. 9, no. 04, pp. 27-28, 2011. View at: Publisher Site | Google Scholar
  14. D. N. Reed, F. O. Gregg, and R. S. Corpe, “Minocycline-induced black bone disease encountered during total knee arthroplasty,” Orthopedics, vol. 35, no. 5, pp. e737–e739, 2012. View at: Publisher Site | Google Scholar
  15. S. S. Chang, E. T. Ek, and V. Pliatsios, “Black bones: a case of incidental discovery of ochronotic arthropathy,” The Medical Journal of Australia, vol. 190, no. 7, p. 390, 2009. View at: Google Scholar
  16. K. Kopeć, D. Kusz, P. Wojciechowski, L. Cieliński, and M. Laszczyca, “Orthopaedic problems in patients affected by alkaptonuria. A case report,” Ortopedia, Traumatologia, Rehabilitacja, vol. 9, no. 2, pp. 206–214, 2007. View at: Google Scholar
  17. S. Kastsiuchenka and A. Mikulka, “Anaesthesia and orphan disease: a patient with alkaptonuria,” European Journal of Anaesthesiology, vol. 30, no. 12, pp. 779-780, 2013. View at: Publisher Site | Google Scholar
  18. M. Harun, Y. Hayrettin, M. Serhat, M. Cuneyt, F. Fırat, and O. Ufuk, “A rare cause of arthropathy: an ochronotic patient with black joints,” International Journal of Surgery Case Reports, vol. 5, no. 8, pp. 554–557, 2014. View at: Publisher Site | Google Scholar
  19. O. Abimbola, G. Hall, and J. D. Zuckerman, “Degenerative arthritis of the knee secondary to ochronosis,” Bulletin of the NYU Hospital for Joint Diseases, vol. 69, no. 4, pp. 331–334, 2011. View at: Google Scholar
  20. K. Araki, A. Sudo, M. Hasegawa, and A. Uchida, “Devastating ochronotic arthropathy with successful bilateral hip and knee arthroplasties,” Journal of Clinical Rheumatology, vol. 15, no. 3, pp. 138–140, 2009. View at: Publisher Site | Google Scholar
  21. S. Demir, “Alkaptonuric ochronosis: a case with multiple joint replacement arthroplasties,” Clinical Rheumatology, vol. 22, no. 6, pp. 437–439, 2003. View at: Publisher Site | Google Scholar
  22. S. Aydoğdu, E. Cullu, M. H. Ozsoy, and H. Sur, “Cementless total knee arthroplasty in ochronotic arthropathy: a case report with a 4-year follow-up,” The Journal of Arthroplasty, vol. 15, no. 4, pp. 539–543, 2000. View at: Publisher Site | Google Scholar
  23. A. A. Fisher and M. W. Davis, “Alkaptonuric ochronosis with aortic valve and joint replacements and femoral fracture: a case report and literature review,” Clinical Medicine & Research, vol. 2, no. 4, pp. 209–215, 2004. View at: Publisher Site | Google Scholar
  24. L. Fontao-Fernández, M. J. Ferreirós-Conde, and J. Otero-Villar, “Ochronotic arthropathy: a presentation of 2 cases,” Revista Española de Cirugía Ortopédica y Traumatología (English Edition), vol. 54, no. 6, pp. 396–398, 2010. View at: Publisher Site | Google Scholar
  25. J. Spencer, C. L. M. Gibbons, R. Sharp, A. Carr, and N. Athanasou, “Arthroplasty for ochronotic arthritisNo failure of 11 replacements in 3 patients followed 6–12 years,” Acta Orthopaedica Scandinavica, vol. 75, no. 3, pp. 355–358, 2004. View at: Publisher Site | Google Scholar
  26. R. Gandhi, D. Tsvetkov, J. R. Davey, and N. N. Mahomed, “Survival and clinical function of cemented and uncemented prostheses in total knee replacement: a meta-analysis,” The Journal of Bone and Joint Surgery. British volume, vol. 91-B, no. 7, pp. 889–895, 2009. View at: Publisher Site | Google Scholar
  27. J. A. Rodriguez, S. Saddler, S. Edelman, and C. S. Ranawat, “Long-term results of total knee arthroplasty in class 3 and 4 rheumatoid arthritis,” The Journal of Arthroplasty, vol. 11, no. 2, pp. 141–145, 1996. View at: Publisher Site | Google Scholar
  28. P. Aglietti, R. Buzzi, F. Segoni, and G. Zaccherotti, “Insall-Burstein posterior-stabilized knee prosthesis in rheumatoid arthritis,” The Journal of Arthroplasty, vol. 10, no. 2, pp. 217–225, 1995. View at: Publisher Site | Google Scholar
  29. F. Matassi, C. Carulli, R. Civinini, and M. Innocenti, “Cemented versus cementless fixation in total knee arthroplasty,” Joints, vol. 01, no. 03, pp. 121–125, 2013. View at: Publisher Site | Google Scholar
  30. N. D. Clement, S. J. Breusch, and L. C. Biant, “Lower limb joint replacement in rheumatoid arthritis,” Journal of Orthopaedic Surgery and Research, vol. 7, no. 1, p. 27, 2012. View at: Publisher Site | Google Scholar
  31. A. Kajino, S. Yoshino, S. Kameyama, M. Kohda, and S. Nagashima, “Comparison of the results of bilateral total knee arthroplasty with and without patellar replacement for rheumatoid arthritis. A follow-up note,” The Journal of Bone and Joint Surgery. American Volume, vol. 79, no. 4, pp. 570–574, 1997. View at: Publisher Site | Google Scholar
  32. A. Assiotis, S. N. M. Sun, S. Mordecai, and J. Hollingdale, “A novel freehand method for patellar resurfacing in total knee replacement,” Acta Orthopaedica Belgica, vol. 81, pp. 340–343, 2015. View at: Google Scholar

Copyright © 2019 Wu Chean Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

501 Views | 263 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.